Predictors of non-sentinel lymph node metastasis in breast cancer patients

被引:80
作者
Goyal, A
Douglas-Jones, A
Newcombe, RG
Mansel, RE [1 ]
机构
[1] Cardiff Univ, Dept Surg, Cardiff, S Glam, Wales
[2] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales
[3] Cardiff Univ, Dept Epidemiol Stat & Publ Hlth, Cardiff, S Glam, Wales
基金
英国医学研究理事会;
关键词
breast cancer; sentinel lymph node biopsy; non-sentinel node metastasis; tumour burden; completion axillary lymph node dissection;
D O I
10.1016/j.ejca.2004.04.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In many patients, the sentinel lymph node (SLN) is the sole site of regional nodal metastasis. This subgroup of patients would not be expected to benefit from completion axillary lymph node dissection (CALND). This study evaluated the factors that may determine the likelihood of additional positive nodes in the axilla in the presence of sentinel node metastasis. A total of 618 breast cancer patients underwent SLN biopsy based on lymphoscintigraphy, intraoperative gamma probe detection, and blue dye mapping using 99mTc-nanocolloid and Patent Blue V injected peritumourally. This was followed by standard axillary node clearance at the same operation. Of the 201 patients with a positive SLN, 105 (52%) patients had no further positive nodes in the axilla, 96 (48%) patients had additional metastasis in non-sentinel lymph nodes (NSLN) upon CALND. In patients with a positive SLN, increasing tumour size and tumour grade significantly increased the frequency of additional positive nodes on univariate analysis. The number of SLNs removed and the number of negative SLNs were significant negative predictors. Increasing tumour burden in the sentinel nodes (determined by the number of positive SLNs) was significantly associated with increasing likelihood of positive NSLNs. Multivariate analysis revealed that the rest of the axilla is more likely to be positive if there are more positive than negative SLNs removed and more likely to be negative otherwise. A group of cases from one centre (Cardiff) were subjected to further detailed analysis. Tumour burden in the positive SLN was assessed by measuring the size of metastasis, percentage replacement of the SLN by tumour and by documenting extracapsular extension (ECE) around the SLN. Of the 64 patients with a positive SLN, 34 (53%) patients had no further positive nodes in the axilla, 30 patients (47%) had additional metastasis in NSLNs upon CALND. Increasing tumour burden in the SLN was associated with additional positive nodes in the axilla. Multivariate analysis revealed that size of the SLN metastasis is the most important predictor of involvement of only the SLN. Overall, in patients with a positive SLN, the difference in the number of positive and negative SLNs removed and size of the metastasis in the SLN, all predicted the frequency of additional positive nodes. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1731 / 1737
页数:7
相关论文
共 25 条
  • [1] Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer
    Abdessalam, SF
    Zervos, EE
    Prasad, M
    Farrar, WB
    Yee, LD
    Walker, MJ
    Carson, WB
    Burak, WE
    [J]. AMERICAN JOURNAL OF SURGERY, 2001, 182 (04) : 316 - 320
  • [2] Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO
  • [3] 2-Y
  • [4] Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis
    Chu, KU
    Turner, RR
    Hansen, NM
    Brennan, MB
    Giuliano, AE
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (08) : 756 - 761
  • [5] Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
    Chu, KU
    Turner, RR
    Hansen, NM
    Brennan, MB
    Bilchik, A
    Giuliano, AE
    [J]. ANNALS OF SURGERY, 1999, 229 (04) : 536 - 541
  • [6] Prognostic significance of occult lymph node metastases in node-negative breast cancer
    Clare, SE
    Sener, SF
    Wilkens, W
    Goldschmidt, R
    Merkel, D
    Winchester, DJ
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (06) : 447 - 451
  • [7] Sentinel node biopsy in breast cancer: ALMANAC trial
    Clarke, D
    Khonji, NI
    Mansel, RE
    [J]. WORLD JOURNAL OF SURGERY, 2001, 25 (06) : 819 - 822
  • [8] Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO
  • [9] 2-H
  • [10] Factors affecting metastases to non-sentinel lymph nodes in breast cancer
    Fleming, FJ
    Kavanagh, D
    Crotty, TB
    Quinn, CM
    McDermott, EW
    O'Higgins, N
    Hill, ADK
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (01) : 73 - 76